Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Annalisa Mondi

Antiretroviral neuropenetration scores better correlate with cognitive performance of HIV-infected patients after accounting for drug susceptibility

scientific article published on 17 December 2014

COVID-19 in people living with HIV: clinical implications of dynamics of immune response to SARS-CoV-2

scientific article published on 25 September 2020

Characterisation of HIV-1 molecular transmission clusters among newly diagnosed individuals infected with non-B subtypes in Italy

scientific article published on 10 May 2019

Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort

Evaluation of emotion processing in HIV-infected patients and correlation with cognitive performance.

scientific article

Increased ophthalmic artery resistance index is associated with cognitive impairment in HIV-infected patients.

scientific article published on 3 August 2012

Lipid-lowering effect and changes in estimated cardiovascular risk after switching to a tenofovir-containing regimen for the treatment of HIV-infected patients

scientific article published on 26 December 2016

Neuropsychological screening tools in Italian HIV+ patients: a comparison of Montreal Cognitive Assessment (MoCA) and Mini Mental State Examination (MMSE).

scientific article published on 16 May 2016

Ophthalmic artery resistance index is increased in HIV-Infected patients and is influenced by protease inhibitors exposure

article

Predictors of first-line antiretroviral therapy discontinuation due to drug-related adverse events in HIV-infected patients: a retrospective cohort study

scientific article

Safety and efficacy of treatment switch to raltegravir plus tenofovir/emtricitabine or abacavir/lamivudine in patients with optimal virological control: 48-week results from a randomized pilot study (Raltegravir Switch for Toxicity or Adverse Events

scientific article published on 28 October 2013

Safety and feasibility of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients on stable treatment with two nucleos(t)ide reverse transcriptase inhibitors + atazanavir/ritonavir with virological suppression (Atazana

scientific article published on 30 January 2013

Simplification to atazanavir/ritonavir+lamivudine in virologically suppressed HIV-infected patients: 24-weeks interim analysis from ATLAS-M trial

scientific article

Single tablet regimens are associated with reduced Efavirenz withdrawal in antiretroviral therapy naïve or switching for simplification HIV-infected patients

scientific article published on 13 January 2014

Switching to lamivudine plus darunavir/r dual therapy in a cohort of treatment-experienced HIV-positive patients: the experience of an Italian centre.

scientific article published on 2 November 2014

Temporal intra‐host variability of mpox virus genomes in multiple body tissues

scientific article published in 2023

Treatment simplification to atazanavir/ritonavir + lamivudine versus maintenance of atazanavir/ritonavir + two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M).

scientific article

Paulina is supported by:

About Paulina

Help